Swell in Off-Label Antipsychotic Prescribing 'Not Harmless'
A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.
Stay updated with breaking news from Manic Depression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.
By opening up about his own mental health, Justin Bullock, MD, MPH, is tackling the stigma and silence around mental illness in medicine.
An expert panel reached consensus that sharing mental health care notes could improve patients' understanding about their diagnosis and treatment plan.
A popular antipsychotic calms patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review suggests.
An inpatient psychiatric diagnosis over an individual's lifetime is significantly associated with poor sleep quality, results from the largest study of its kind show.